Skip to main content

Peer Review reports

From: Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli

Original Submission
8 May 2016 Submitted Original manuscript
15 Aug 2016 Reviewed Reviewer Report - Chanwit Tribuddharat
8 Oct 2016 Reviewed Reviewer Report - JONATHAN IREDELL
2 Dec 2016 Author responded Author comments - Yu Bin Seo
Resubmission - Version 2
2 Dec 2016 Submitted Manuscript version 2
23 Dec 2016 Reviewed Reviewer Report - Chanwit Tribuddharat
17 Apr 2017 Author responded Author comments - Yu Bin Seo
Resubmission - Version 3
17 Apr 2017 Submitted Manuscript version 3
29 May 2017 Author responded Author comments - Yu Bin Seo
Resubmission - Version 4
29 May 2017 Submitted Manuscript version 4
Publishing
30 May 2017 Editorially accepted
7 Jun 2017 Article published 10.1186/s12879-017-2502-x

You can find further information about peer review here.

Back to article page